1. Home
  2. VRCA vs HFRO Comparison

VRCA vs HFRO Comparison

Compare VRCA & HFRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRCA
  • HFRO
  • Stock Information
  • Founded
  • VRCA 2013
  • HFRO 2000
  • Country
  • VRCA United States
  • HFRO United States
  • Employees
  • VRCA N/A
  • HFRO N/A
  • Industry
  • VRCA Biotechnology: Pharmaceutical Preparations
  • HFRO Finance/Investors Services
  • Sector
  • VRCA Health Care
  • HFRO Finance
  • Exchange
  • VRCA Nasdaq
  • HFRO Nasdaq
  • Market Cap
  • VRCA 363.1M
  • HFRO 388.8M
  • IPO Year
  • VRCA 2018
  • HFRO N/A
  • Fundamental
  • Price
  • VRCA $0.69
  • HFRO $5.33
  • Analyst Decision
  • VRCA Hold
  • HFRO
  • Analyst Count
  • VRCA 5
  • HFRO 0
  • Target Price
  • VRCA $6.00
  • HFRO N/A
  • AVG Volume (30 Days)
  • VRCA 749.9K
  • HFRO 421.7K
  • Earning Date
  • VRCA 11-04-2024
  • HFRO 01-01-0001
  • Dividend Yield
  • VRCA N/A
  • HFRO 12.00%
  • EPS Growth
  • VRCA N/A
  • HFRO N/A
  • EPS
  • VRCA N/A
  • HFRO 1.23
  • Revenue
  • VRCA $9,210,000.00
  • HFRO $44,535,929.00
  • Revenue This Year
  • VRCA $54.16
  • HFRO N/A
  • Revenue Next Year
  • VRCA $99.78
  • HFRO N/A
  • P/E Ratio
  • VRCA N/A
  • HFRO $5.50
  • Revenue Growth
  • VRCA 187.45
  • HFRO N/A
  • 52 Week Low
  • VRCA $0.61
  • HFRO $5.92
  • 52 Week High
  • VRCA $11.41
  • HFRO $9.38
  • Technical
  • Relative Strength Index (RSI)
  • VRCA 33.00
  • HFRO 32.01
  • Support Level
  • VRCA $0.61
  • HFRO $5.73
  • Resistance Level
  • VRCA $1.32
  • HFRO $5.82
  • Average True Range (ATR)
  • VRCA 0.11
  • HFRO 0.11
  • MACD
  • VRCA -0.02
  • HFRO -0.05
  • Stochastic Oscillator
  • VRCA 12.08
  • HFRO 7.45

About VRCA Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.

About HFRO Highland Opportunities and Income Fund of Beneficial Interest

Highland Opportunities and Income Fund is a non-diversified, closed-end management investment company. Its investment objective is to Income Fund seeks growth of capital along with income. The company's portfolio of investments includes different industry investments such as Financial, Communication Services, Energy, Healthcare, Materials, and others.

Share on Social Networks: